DCLK1 and colorectal carcinoma: In consistent with these studies, we found that knock‐down of DCLK1 resulted in the weakened proliferative potential and self‐renewal ability of CRC cells, and the decreased proportion of CD44+ and CD133+ CRC cells (Figures 2A and S2A,B).